Organon (OGN) Director Shalini Sharp Receives $240K Phantom Stock Award

What Happened Shalini Sharp, a director of Organon & Co. (OGN), was granted 17,857.143 phantom stock units on 2026-06-12 at a reference price of $13.44 per unit, with a total grant value of $240,000. This was an award (derivative grant), not an open-market purchase or sale.

Key Details

• Transaction type: Grant / Award of phantom stock units (code A — derivative).
• Date of transaction: 2026-06-12; Form 4 filed 2026-06-15 (within the normal reporting window).
• Units granted: 17,857.143 phantom stock units; price used for valuation: $13.44; total value: $240,000.
• Shares/units owned after transaction: Not specified in the filing. (F3 notes holdings include phantom stock from dividend reinvestments on 9/11/2025, 12/11/2025, 3/12/2026 and 6/11/2026.)
• Plan and settlement: Units granted under the Organon Non-Employee Director Savings Plan; each phantom unit is a 1-for-1 economic equivalent of a share (F1). Phantom units are payable in cash upon settlement after the director’s termination of service, per plan terms (F2).
• No indication of a 10b5-1 plan, sale, gift, tax withholding, or immediate conversion to shares in this filing.

Context Phantom stock units are derivative awards that track the economic value of common shares but do not represent actual stock ownership until settled; in this case they are payable in cash after Sharp leaves the board. Because this is a compensation grant to a non-employee director, it signals routine director compensation rather than an open-market buy or sell by the insider.